Innovative and Non-invasive Therapy for Treatment of Hypertension
Hypertension is a leading attributable cause of death worldwide. It is a significant, growing global healthcare problem affecting over one billion people and is associated with an increased risk of heart attack, stroke, heart failure, kidney disease and death. Kona Medical, Inc. is a privately held company developing an innovative and non-invasive therapy for treatment of hypertension.
Company
Technology
Latest News
Kona Medical, Inc. is a privately held company developing an innovative and non-invasive therapy for treatment of hypertension (high blood pressure). Kona was founded in 2009, is headquartered near Seattle in Bellevue, Washington, and is actively supported by leading medical technology investors.
Kona is developing an ultrasound-based approach to address severe high blood pressure (hypertension) through ablation of the renal nerves. Renal nerves are located proximal to the renal arteries, which provide blood flow to the kidneys. Renal nerves are part of the sympathetic nervous system and play a significant role in determining blood pressure.